Legal & General Group’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-299,836
| Closed | -$463K | – | 3429 |
|
|
2025
Q1 | $463K | Buy |
299,836
+2,100
| +0.7% | +$3.25K | ﹤0.01% | 2420 |
|
|
2024
Q4 | $697K | Buy |
297,736
+237,224
| +392% | +$555K | ﹤0.01% | 2349 |
|
|
2024
Q3 | $219K | Hold |
60,512
| – | – | ﹤0.01% | 2666 |
|
|
2024
Q2 | $211K | Buy |
+60,512
| New | +$211K | ﹤0.01% | 2659 |
|
|
2022
Q4 | – | Sell |
-67,517
| Closed | -$146K | – | 3419 |
|
|
2022
Q3 | $146K | Hold |
67,517
| – | – | ﹤0.01% | 2717 |
|
|
2022
Q2 | $192K | Buy |
67,517
+34,813
| +106% | +$99K | ﹤0.01% | 2651 |
|
|
2022
Q1 | $137K | Hold |
32,704
| – | – | ﹤0.01% | 2791 |
|
|
2021
Q4 | $170K | Buy |
32,704
+3,720
| +13% | +$19.3K | ﹤0.01% | 2774 |
|
|
2021
Q3 | $190K | Buy |
28,984
+7,647
| +36% | +$50.1K | ﹤0.01% | 2709 |
|
|
2021
Q2 | $142K | Buy |
21,337
+10,446
| +96% | +$69.5K | ﹤0.01% | 2623 |
|
|
2021
Q1 | $63K | Hold |
10,891
| – | – | ﹤0.01% | 2749 |
|
|
2020
Q4 | $97K | Buy |
10,891
+2,231
| +26% | +$19.9K | ﹤0.01% | 2594 |
|
|
2020
Q3 | $100K | Hold |
8,660
| – | – | ﹤0.01% | 2491 |
|
|
2020
Q2 | $138K | Buy |
8,660
+4,037
| +87% | +$64.3K | ﹤0.01% | 2446 |
|
|
2020
Q1 | $27K | Buy |
4,623
+1,108
| +32% | +$6.47K | ﹤0.01% | 2794 |
|
|
2019
Q4 | $46K | Buy |
3,515
+3,369
| +2,308% | +$44.1K | ﹤0.01% | 2839 |
|
|
2019
Q3 | $2K | Hold |
146
| – | – | ﹤0.01% | 3342 |
|
|
2019
Q2 | $2K | Buy |
146
+100
| +217% | +$1.37K | ﹤0.01% | 3477 |
|
|
2019
Q1 | $1K | Hold |
46
| – | – | ﹤0.01% | 3341 |
|
|
2018
Q4 | $1K | Buy |
+46
| New | +$1K | ﹤0.01% | 3375 |
|